Breman JG: The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. Am J Trop Med Hyg. 2001, 64: 1-11.
CAS
PubMed
Google Scholar
Soe S, Theisen M, Roussilhon C, Aye KS, Druilhe P: Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein. Infect Immun. 2004, 72: 247-252. 10.1128/IAI.72.1.247-252.2004.
Article
CAS
PubMed
PubMed Central
Google Scholar
Riley EM, Allen SJ, Wheeler JG, Blackman MJ, Bennett S, Takacs B, et al: Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol. 1992, 14: 321-337. 10.1111/j.1365-3024.1992.tb00471.x.
Article
CAS
PubMed
Google Scholar
Druilhe P, Perignon JL: Mechanisms of defense against P. falciparum asexual blood stages in humans. Immunol Lett. 1994, 41: 115-120. 10.1016/0165-2478(94)90118-X.
Article
CAS
PubMed
Google Scholar
Perignon JL, Druilhe P: Immune mechanisms underlying the premunition against Plasmodium falciparum malaria. Mem Inst Oswaldo Cruz. 1994, 89 (Suppl 2): 51-53.
Article
PubMed
Google Scholar
Alonso PL, Sacarlal J, Aponte JJ, Leach A, Macete E, Milman J, et al: Efficacy of the RTS, S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet. 2004, 364: 1411-1420. 10.1016/S0140-6736(04)17223-1.
Article
CAS
PubMed
Google Scholar
Ballou WR, Arevalo-Herrera M, Carucci D, Richie TL, Corradin G, Diggs C, et al: Update on the clinical development of candidate malaria vaccines. Am J Trop Med Hyg. 2004, 71: 239-247.
PubMed
Google Scholar
Bejon P, Peshu N, Gilbert SC, Lowe BS, Molyneux CS, Forsdyke J, et al: Safety profile of the viral vectors of attenuated fowlpox strain FP9 and modified vaccinia virus Ankara recombinant for either of 2 preerythrocytic malaria antigens, ME-TRAP or the circumsporozoite protein, in children and adults in Kenya. Clin Infect Dis. 2006, 42: 1102-1110. 10.1086/501459.
Article
CAS
PubMed
Google Scholar
Oeuvray C, Bouharoun-Tayoun H, Gras-Masse H, Bottius E, Kaidoh T, Aikawa M, et al: Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes. Blood. 1994, 84: 1594-1602.
CAS
PubMed
Google Scholar
Carvalho LJ, Oliveira SG, Theisen M, Alves FA, Andrade MC, Zanini GM, et al: Immunization of Saimiri sciureus monkeys with Plasmodium falciparum merozoite surface protein-3 and glutamate-rich protein suggests that protection is related to antibody levels. Scand J Immunol. 2004, 59: 363-372. 10.1111/j.0300-9475.2004.01409.x.
Article
CAS
PubMed
Google Scholar
Sabchareon A, Burnouf T, Ouattara D, Attanath P, Bouharoun-Tayoun H, Chantavanich P, et al: Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am J Trop Med Hyg. 1991, 45: 297-308.
CAS
PubMed
Google Scholar
Jafarshad A, Dziegiel MH, Lundquist R, Nielsen LK, Singh S, Druilhe PL: A novel antibody-dependent cellular cytotoxicity mechanism involved in defense against malaria requires costimulation of monocytes FcgammaRII and FcgammaRIII. J Immunol. 2007, 178: 3099-3106.
Article
CAS
PubMed
Google Scholar
Bouharoun-Tayoun H, Oeuvray C, Lunel F, Druilhe P: Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. J Exp Med. 1995, 182: 409-418. 10.1084/jem.182.2.409.
Article
CAS
PubMed
Google Scholar
Ndungu FM, Bull PC, Ross A, Lowe BS, Kabiru E, Marsh K: Naturally acquired immunoglobulin (Ig)G subclass antibodies to crude asexual Plasmodium falciparum lysates: evidence for association with protection for IgG1 and disease for IgG2. Parasite Immunol. 2002, 24: 77-82. 10.1046/j.0141-9838.2001.00440.x.
Article
CAS
PubMed
Google Scholar
Sirima SB, Nebie I, Ouedraogo A, Tiono AB, Konate AT, Gansane A, et al: Safety and immunogenicity of the Plasmodium falciparum merozoite surface protein-3 long synthetic peptide (MSP3-LSP) malaria vaccine in healthy, semi-immune adult males in Burkina Faso, West Africa. Vaccine. 2007, 25: 2723-2732. 10.1016/j.vaccine.2006.05.090.
Article
CAS
PubMed
Google Scholar
Lusingu JPA, Gesase S, Msham S, Francis F, Lemnge M, Seth M, Sembuche S, Rutta A, Minja D, Segeja MD, Bosomprah S, Cousens S, Noor R, Chilengi R, Druilhe P: Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12-24 months. Malaria J. 2009, 8: 163-10.1186/1475-2875-8-163.
Article
Google Scholar
Bodker R, Akida J, Shayo D, Kisinza W, Msangeni HA, Pedersen EM, et al: Relationship between altitude and intensity of malaria transmission in the Usambara Mountains, Tanzania. J Med Entomol. 2003, 40: 706-717. 10.1603/0022-2585-40.5.706.
Article
CAS
PubMed
Google Scholar
Maxwell CA, Chambo W, Mwaimu M, Magogo F, Carneiro IA, Curtis CF: Variation of malaria transmission and morbidity with altitude in Tanzania and with introduction of alphacypermethrin treated nets. Malar J. 2003, 2: 28-10.1186/1475-2875-2-28.
Article
PubMed
PubMed Central
Google Scholar
Mmbando BP, Segeja MD, Msangeni HA, Sembuche SH, Ishengoma DS, Seth MD, Francis F, Rutta AS, Kamugisha ML, Lemnge MM: Epidemiology of malaria in an area prepared for clinical trials in Korogwe, north-eastern Tanzania. Malaria J. 2009, 8: 165-10.1186/1475-2875-8-165.
Article
Google Scholar
Lusingu JP, Vestergaard LS, Mmbando BP, Drakeley CJ, Jones C, Akida J, et al: Malaria morbidity and immunity among residents of villages with different Plasmodium falciparum transmission intensity in North-Eastern Tanzania. Malar J. 2004, 3: 26-10.1186/1475-2875-3-26.
Article
PubMed
PubMed Central
Google Scholar
Mnzava AE, Kilama WL: Observations on the distribution of the Anopheles gambiae complex in Tanzania. Acta Trop. 1986, 43: 277-282.
CAS
PubMed
Google Scholar
Reyburn H, Mbatia R, Drakeley C, Bruce J, Carneiro I, Olomi R, Cox J, Nkya WM, Lemnge M, Greenwood BM, Riley EM: Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria. JAMA. 2005, 293 (12): 1461-1470. 10.1001/jama.293.12.1461.
Article
CAS
PubMed
Google Scholar
Nebie I, Tiono AB, Diallo DA, Samandoulougou S, Diarra A, Konate AT, Cuzin-Ouattara N, Thiesen M, Corradin G, Cousens S, Ouattara AS, IIboudo-Sanogo E, Sirima BS: Do antibody responses to malaria vaccine candidates influenced by the levels of malaria transmission protect from malaria?. Tropical Medicine and International Health. 2008, 13 (2): 229-237.
Article
CAS
PubMed
Google Scholar
Lusingu JPA, Gesase S, Msham S, Francis F, Lemnge M, Seth M, Sembuche S, Rutta A, Minja D, Segeja MD, Bosomprah S, Cousens S, Noor R, Chilengi R, Druilhe P: Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12-24 months. Malaria J. 2009, 8: 163-10.1186/1475-2875-8-163.
Article
Google Scholar
Nebie I, Diarra A, Ouedraogo A, Soulama I, Bougouma EC, Tiono AB, et al: Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa. Infect Immun. 2008, 76: 759-766. 10.1128/IAI.01147-07.
Article
CAS
PubMed
Google Scholar
Soe S, Khin SA, Htay A, Nay W, Tin A, Than S, et al: Premunition against Plasmodium falciparum in a malaria hyperendemic village in Myanmar. Trans R Soc Trop Med Hyg. 2001, 95: 81-84. 10.1016/S0035-9203(01)90342-6.
Article
Google Scholar
Dodoo D, Aikins A, Kusi KA, Lamptey H, Remarque E, Milligan P, et al: Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children. Malar J. 2008, 7: 142-10.1186/1475-2875-7-142.
Article
PubMed
PubMed Central
Google Scholar
Drakeley CJ, Corran PH, Coleman PG, et al: Estimating medium and long term trends in malaria transmission by using serological markers of malaria exposure. Proceedings of the National Academy of Sciences USA. 102: 5108-5113. 10.1073/pnas.0408725102.
Tongren JE, Drakeley CJ, McDonald SL, Reyburn HG, Manjurano A, Nkya WM, Lemnge MM, Gowda CD, Todd JE, Corran PH, Riley EM: Target antigen, age and duration of antigen exposure independently regulate Immunoglobulin G subclass switching in malaria. Infection Immun. 2006, 74: 257-264. 10.1128/IAI.74.1.257-264.2006.
Article
CAS
Google Scholar
Pleass RJ, Woof JM: Fc receptors and immunity to parasites. Trends Parasitol. 2001, 17: 545-551. 10.1016/S1471-4922(01)02086-4.
Article
CAS
PubMed
Google Scholar
Askjaer N, Maxwell C, Chambo W, et al: Insecticide treated bednets reduce plasma antibody levels and limit the repertoire of antibodies to Plasmodium falciparum variant surface antigens. Clinical and disgnostic Laboratory Immunology. 2001, 8: 1289-1291.
CAS
Google Scholar
Nebie I, Cuzin-Ouattara N, Diallo DA, et al: Humoral responses to defined malaria antigens in children living since birth under insecticide treated curtains in Burkina Faso. Acta Tropics. 2003, 88: 17-25. 10.1016/S0001-706X(03)00189-X.
Article
CAS
Google Scholar